CNPR Healthcare Industry Knowledge & Drug Approval Process 4 — Questions and Answers
Question 1: A pharmaceutical company submits a Biologics License Application (BLA) instead of an NDA when the product is:
- A small-molecule chemical synthesized in a laboratory
- A large-molecule product derived from living cells or organisms such as a vaccine or monoclonal antibody (Correct answer)
- A generic version of an existing prescription drug
- A medical device that delivers a drug transdermally
Correct answer: A large-molecule product derived from living cells or organisms such as a vaccine or monoclonal antibody
BLAs are required for biologics — complex molecules like proteins, antibodies, and gene therapies derived from biological sources — reviewed by CBER or CDER.
Question 2: Which government program provides prescription drug coverage primarily for Americans aged 65 and older?
- Medicaid
- Medicare Part D (Correct answer)
- CHIP
- TRICARE
Correct answer: Medicare Part D
Medicare Part D is the voluntary outpatient prescription drug benefit for Medicare beneficiaries, administered through approved private plan sponsors.
Question 3: What is the significance of a drug's half-life to a pharmaceutical sales representative?
- It determines how long the drug's patent will last
- It influences dosing frequency, which is a key selling point related to patient convenience and adherence (Correct answer)
- It indicates the drug's shelf life in a pharmacy
- It establishes the maximum dose a patient can safely receive
Correct answer: It influences dosing frequency, which is a key selling point related to patient convenience and adherence
A longer half-life may allow once-daily dosing, which representatives can highlight as improving patient adherence compared to drugs requiring multiple daily doses.
Question 4: Under the PhRMA Code on Interactions with Healthcare Professionals, which of the following activities is prohibited?
- Providing educational grants to accredited medical schools
- Offering modest meals in connection with a bona fide educational presentation
- Giving physicians tickets to a sporting event as a token of appreciation (Correct answer)
- Distributing medical journal reprints relevant to the drug being promoted
Correct answer: Giving physicians tickets to a sporting event as a token of appreciation
The PhRMA Code prohibits giving entertainment or recreational items of value, such as sports tickets, regardless of their cost.
Question 5: What is a 'Paragraph IV certification' in the context of generic drug applications (ANDAs)?
- A certification that the generic drug has the same inactive ingredients as the brand
- A certification that the brand's listed patent is invalid or will not be infringed by the generic (Correct answer)
- A statement that the generic will only be marketed after the brand's patent expires
- A pledge by the generic manufacturer to conduct post-market safety studies
Correct answer: A certification that the brand's listed patent is invalid or will not be infringed by the generic
A Paragraph IV certification is a legal challenge asserting that listed patents are invalid or will not be infringed, which often triggers 30-month litigation stays.
Question 6: Which federal law requires pharmaceutical manufacturers to report serious and unexpected adverse drug reactions to the FDA?
- The Kefauver-Harris Amendment
- The Drug Price Competition and Patent Term Restoration Act
- The Federal Food, Drug, and Cosmetic Act (FD&C Act) post-marketing reporting requirements (Correct answer)
- The Controlled Substances Act
Correct answer: The Federal Food, Drug, and Cosmetic Act (FD&C Act) post-marketing reporting requirements
The FD&C Act's post-marketing surveillance provisions mandate that manufacturers submit MedWatch reports for serious unexpected adverse events discovered after drug approval.
Question 7: A physician who sees patients primarily in a hospital setting and makes decisions about which drugs appear on the hospital's approved drug list is best described as:
- A retail pharmacist
- A primary care physician in a group practice
- A hospitalist or specialist influencing the hospital formulary (Correct answer)
- A long-term care nurse practitioner
Correct answer: A hospitalist or specialist influencing the hospital formulary
Hospital-based physicians, including hospitalists and specialists, often serve on Pharmacy and Therapeutics (P&T) committees that control the institutional formulary.
CNPR Healthcare Industry Knowledge & Drug Approval Process 4
A pharmaceutical company submits a Biologics License Application (BLA) instead of an NDA when the product is: